Table 1

Digital health and the End TB Strategy: a history of the future?

Domains*Examples from…
Integrated, patient-centred care and preventionVideo-observed therapyEdible microchips transmitting to mobile electronic devices; registering the gesture of a specific patient taking a given pill
Databasing laboratory results and patient parametersConnected diagnostics
Tracking disease biomarkers via ‘wearables’
Point of care testingDigitisation of biological material (genome, chemistry), integration of data from multiple sources and remote consultation of experts
Standardising anti-TB medicationIntimate monitoring of biomarkers to optimise care
Internet-based reference and eLearning contentDecision aids informed by Big Data; advanced machine learning techniques
Alerting people of exposure risks from real-time analysis of environmental and other data
Bold policies and supportive systemsData management shifts from paper to electronic systemsSeamless interoperability of computer networks and cloud-based data sets
GIS mapping of patients and service providersReal-time localisation of individuals
Unique identifiers which incorporate biomarker data
Conditional cash transfers as an extension of micro-financingRewarding behaviour linked to therapeutic effect
Personal genome data as a patient asset
Strengthening logistic information systemsReal-time tracking of equipment and consumables
Intensified research and innovationDigitising data from studiesMining data sets In silico modelling of interventions using new drugs and vaccines
eLearning to build capacity in conducting and translating research
  • *Corresponding to the three pillars of the WHO End TB Strategy.3

  • TB, tuberculosis.